Insider Transactions in Q3 2023 at Metlife Inc (MET)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2023
|
Jeh C. Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.77%
|
$910
$65.93 P/Share
|
|
Sep 14
2023
|
Catherine R Kinney Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+0.48%
|
$18,395
$65.93 P/Share
|
|
Sep 14
2023
|
Edward J Kelly Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+0.78%
|
$15,860
$65.93 P/Share
|
|
Sep 14
2023
|
Robert Glenn Hubbard Director |
BUY
Grant, award, or other acquisition
|
Direct |
626
+0.71%
|
$40,690
$65.93 P/Share
|
|
Sep 14
2023
|
Gerald L Hassell Director |
BUY
Grant, award, or other acquisition
|
Direct |
149
+0.51%
|
$9,685
$65.93 P/Share
|
|
Sep 14
2023
|
William E Kennard Director |
BUY
Grant, award, or other acquisition
|
Direct |
288
+0.78%
|
$18,720
$65.93 P/Share
|
|
Sep 14
2023
|
Cheryl W Grise Director |
BUY
Grant, award, or other acquisition
|
Direct |
593
+0.73%
|
$38,545
$65.93 P/Share
|
|
Sep 14
2023
|
David L Herzog Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.21%
|
$2,990
$65.93 P/Share
|
|
Sep 14
2023
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.78%
|
$8,320
$65.93 P/Share
|
|
Aug 31
2023
|
John D. Mc Callion EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,841
+6.82%
|
-
|
|
Aug 31
2023
|
Marlene Debel EVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,894
+8.45%
|
-
|
|
Aug 31
2023
|
Ramy Tadros President, U.S. Business |
BUY
Grant, award, or other acquisition
|
Direct |
7,894
+6.36%
|
-
|
|
Aug 31
2023
|
Bill Pappas EVP, Global Tech. & Ops. |
BUY
Grant, award, or other acquisition
|
Direct |
7,894
+16.65%
|
-
|
|
Aug 09
2023
|
Marlene Debel EVP & Chief Risk Officer |
SELL
Open market or private sale
|
Direct |
9,391
-10.79%
|
$591,633
$63.18 P/Share
|
|
Aug 09
2023
|
Marlene Debel EVP & Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,911
+11.14%
|
$490,995
$45.15 P/Share
|